Global Leber Congenital Amaurosis (LCA) Industry Research Report 2020, Forecast to 2025

August 2020 | 105 pages | ID: G65D407AC39BEN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Leber Congenital Amaurosis (LCA) market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Leber Congenital Amaurosis (LCA) is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Leber Congenital Amaurosis (LCA) industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Leber Congenital Amaurosis (LCA) by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Leber Congenital Amaurosis (LCA) market are discussed.

The market is segmented by types:

• Infantile Type
• Juvenile Type

It can be also divided by applications:

• Hospitals
• Eye Clinics
• Medical Research Institute
• Other

And this report covers the historical situation, present status and the future prospects of the global Leber Congenital Amaurosis (LCA) market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• AmpliPhi Biosciences
• ProQR Therapeutics
• Editas Medicine
• Novelion Therapeutics
• Spark Therapeutics

Report Includes:

• xx data tables and xx additional tables
• An overview of global Leber Congenital Amaurosis (LCA) market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Leber Congenital Amaurosis (LCA) market
• Profiles of major players in the industry, including%li% AmpliPhi Biosciences,%li% ProQR Therapeutics,%li% Editas Medicine,%li% Novelion Therapeutics,%li% Spark Therapeutics.....

Research Objectives

• To study and analyze the global Leber Congenital Amaurosis (LCA) consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Leber Congenital Amaurosis (LCA) market by identifying its various subsegments.
• Focuses on the key global Leber Congenital Amaurosis (LCA) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Leber Congenital Amaurosis (LCA) with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Leber Congenital Amaurosis (LCA) submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Leber Congenital Amaurosis (LCA) Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Leber Congenital Amaurosis (LCA) Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 LEBER CONGENITAL AMAUROSIS (LCA) INDUSTRY OVERVIEW

2.1 Global Leber Congenital Amaurosis (LCA) Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Leber Congenital Amaurosis (LCA) Global Import Market Analysis
  2.1.2 Leber Congenital Amaurosis (LCA) Global Export Market Analysis
  2.1.3 Leber Congenital Amaurosis (LCA) Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Infantile Type
  2.2.2 Juvenile Type
2.3 Market Analysis by Application
  2.3.1 Hospitals
  2.3.2 Eye Clinics
  2.3.3 Medical Research Institute
  2.3.4 Other
2.4 Global Leber Congenital Amaurosis (LCA) Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Leber Congenital Amaurosis (LCA) Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Leber Congenital Amaurosis (LCA) Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Leber Congenital Amaurosis (LCA) Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Leber Congenital Amaurosis (LCA) Manufacturer Market Share
  2.4.5 Top 10 Leber Congenital Amaurosis (LCA) Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Leber Congenital Amaurosis (LCA) Market
  2.4.7 Key Manufacturers Leber Congenital Amaurosis (LCA) Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Leber Congenital Amaurosis (LCA) Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Leber Congenital Amaurosis (LCA) Industry Impact
  2.7.1 How the Covid-19 is Affecting the Leber Congenital Amaurosis (LCA) Industry
  2.7.2 Leber Congenital Amaurosis (LCA) Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Leber Congenital Amaurosis (LCA) Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Leber Congenital Amaurosis (LCA) Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL LEBER CONGENITAL AMAUROSIS (LCA) MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Leber Congenital Amaurosis (LCA) Sales Market Share by Region
4.2 Global Leber Congenital Amaurosis (LCA) Revenue Market Share by Region (2015-2019)
4.3 Global Leber Congenital Amaurosis (LCA) Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Leber Congenital Amaurosis (LCA) Market Size Detail
  4.4.1 North America Leber Congenital Amaurosis (LCA) Sales Growth Rate (2015-2020)
  4.4.2 North America Leber Congenital Amaurosis (LCA) Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Leber Congenital Amaurosis (LCA) Market Size Detail
  4.5.1 Europe Leber Congenital Amaurosis (LCA) Sales Growth Rate (2015-2020)
  4.5.2 Europe Leber Congenital Amaurosis (LCA) Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Leber Congenital Amaurosis (LCA) Market Size Detail
  4.6.1 Japan Leber Congenital Amaurosis (LCA) Sales Growth Rate (2015-2020)
  4.6.2 Japan Leber Congenital Amaurosis (LCA) Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Leber Congenital Amaurosis (LCA) Market Size Detail
  4.7.1 China Leber Congenital Amaurosis (LCA) Sales Growth Rate (2015-2020)
  4.7.2 China Leber Congenital Amaurosis (LCA) Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL LEBER CONGENITAL AMAUROSIS (LCA) MARKET SEGMENT BY TYPE

5.1 Global Leber Congenital Amaurosis (LCA) Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Leber Congenital Amaurosis (LCA) Sales and Market Share by Type (2015-2020)
  5.1.2 Global Leber Congenital Amaurosis (LCA) Revenue and Market Share by Type (2015-2020)
5.2 Infantile Type Sales Growth Rate and Price
  5.2.1 Global Infantile Type Sales Growth Rate (2015-2020)
  5.2.2 Global Infantile Type Price (2015-2020)
5.3 Juvenile Type Sales Growth Rate and Price
  5.3.1 Global Juvenile Type Sales Growth Rate (2015-2020)
  5.3.2 Global Juvenile Type Price (2015-2020)

6 GLOBAL LEBER CONGENITAL AMAUROSIS (LCA) MARKET SEGMENT BY APPLICATION

6.1 Global Leber Congenital Amaurosis (LCA)Sales Market Share by Application (2015-2020)
6.2 Hospitals Sales Growth Rate (2015-2020)
6.3 Eye Clinics Sales Growth Rate (2015-2020)
6.4 Medical Research Institute Sales Growth Rate (2015-2020)
6.5 Other Sales Growth Rate (2015-2020)

7 GLOBAL LEBER CONGENITAL AMAUROSIS (LCA) MARKET FORECAST

7.1 Global Leber Congenital Amaurosis (LCA) Sales, Revenue Forecast
  7.1.1 Global Leber Congenital Amaurosis (LCA) Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Leber Congenital Amaurosis (LCA) Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Leber Congenital Amaurosis (LCA) Price and Trend Forecast (2020-2025)
7.2 Global Leber Congenital Amaurosis (LCA) Sales Forecast by Region (2020-2025)
  7.2.1 North America Leber Congenital Amaurosis (LCA) Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Leber Congenital Amaurosis (LCA) Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Leber Congenital Amaurosis (LCA) Production, Revenue Forecast (2020-2025)
  7.2.4 China Leber Congenital Amaurosis (LCA) Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF LEBER CONGENITAL AMAUROSIS (LCA) INDUSTRY KEY MANUFACTURERS

8.1 AmpliPhi Biosciences
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 AmpliPhi Biosciences Leber Congenital Amaurosis (LCA) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 AmpliPhi Biosciences News
8.2 ProQR Therapeutics
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 ProQR Therapeutics Leber Congenital Amaurosis (LCA) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 ProQR Therapeutics News
8.3 Editas Medicine
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Editas Medicine Leber Congenital Amaurosis (LCA) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Editas Medicine News
8.4 Novelion Therapeutics
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 Novelion Therapeutics Leber Congenital Amaurosis (LCA) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 Novelion Therapeutics News
8.5 Spark Therapeutics
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 Spark Therapeutics Leber Congenital Amaurosis (LCA) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 Spark Therapeutics News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Leber Congenital Amaurosis (LCA) Picture
Figure Research Programs/Design for This Report
Figure Global Leber Congenital Amaurosis (LCA) Market by Regions (2019)
Table Global Market Leber Congenital Amaurosis (LCA) Comparison by Regions (M USD) 2019-2025
Table Global Leber Congenital Amaurosis (LCA) Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Leber Congenital Amaurosis (LCA) by Type in 2019
Figure Infantile Type Picture
Figure Juvenile Type Picture
Table Global Leber Congenital Amaurosis (LCA) Sales by Application (2019-2025)
Figure Global Leber Congenital Amaurosis (LCA) Sales Market Share by Application in 2019
Figure Hospitals Picture
Figure Eye Clinics Picture
Figure Medical Research Institute Picture
Figure Other Picture
Table Global Leber Congenital Amaurosis (LCA) Sales by Manufacturer (2018-2020)
Figure Global Leber Congenital Amaurosis (LCA) Sales Market Share by Manufacturer in 2019
Table Global Leber Congenital Amaurosis (LCA) Revenue by Manufacturer (2018-2020)
Figure Global Leber Congenital Amaurosis (LCA) Revenue Market Share by Manufacturer in 2019
Table Global Leber Congenital Amaurosis (LCA) Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Leber Congenital Amaurosis (LCA) Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Leber Congenital Amaurosis (LCA) Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Leber Congenital Amaurosis (LCA) Market
Table Key Manufacturers Leber Congenital Amaurosis (LCA) Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Leber Congenital Amaurosis (LCA)
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Leber Congenital Amaurosis (LCA) Sales (K Units) by Region (2015-2020)
Table Global Leber Congenital Amaurosis (LCA) Sales Market Share by Region (2015-2019)
Figure Global Leber Congenital Amaurosis (LCA) Sales Market Share by Region (2015-2019)
Figure Global Leber Congenital Amaurosis (LCA) Sales Market Share by Region in 2018
Table Global Leber Congenital Amaurosis (LCA) Revenue (Million US$) by Region (2015-2020)
Table Global Leber Congenital Amaurosis (LCA) Revenue Market Share by Region (2015-2020)
Figure Global Leber Congenital Amaurosis (LCA) Revenue Market Share by Region (2015-2020)
Figure Global Leber Congenital Amaurosis (LCA) Revenue Market Share by Region in 2019
Table Global Leber Congenital Amaurosis (LCA) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Leber Congenital Amaurosis (LCA) Sales (K Units) Growth Rate (2015-2020)
Table North America Leber Congenital Amaurosis (LCA) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Leber Congenital Amaurosis (LCA) Sales (K Units) Growth Rate (2015-2020)
Table Europe Leber Congenital Amaurosis (LCA) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Leber Congenital Amaurosis (LCA) Sales (K Units) Growth Rate (2015-2020)
Table Japan Leber Congenital Amaurosis (LCA) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Leber Congenital Amaurosis (LCA) Sales (K Units) Growth Rate (2015-2020)
Table China Leber Congenital Amaurosis (LCA) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Leber Congenital Amaurosis (LCA) Sales by Type (2015-2020)
Table Global Leber Congenital Amaurosis (LCA) Sales Market Share by Type (2015-2020)
Figure Global Leber Congenital Amaurosis (LCA) Sales Market Share by Type in 2019
Table Global Leber Congenital Amaurosis (LCA) Revenue by Type (2015-2020)
Table Global Leber Congenital Amaurosis (LCA) Revenue Market Share by Type (2015-2020)
Figure Global Leber Congenital Amaurosis (LCA) Revenue Market Share by Type in 2019
Figure Global Infantile Type Sales Growth Rate (2015-2020)
Figure Global Infantile Type Price (2015-2020)
Figure Global Juvenile Type Sales Growth Rate (2015-2020)
Figure Global Juvenile Type Price (2015-2020)
Table Global Leber Congenital Amaurosis (LCA) Sales by Application (2015-2020)
Table Global Leber Congenital Amaurosis (LCA) Sales Market Share by Application (2015-2020)
Figure Global Leber Congenital Amaurosis (LCA) Sales Market Share by Application in 2019
Figure Global Hospitals Sales Growth Rate (2015-2020)
Figure Global Eye Clinics Sales Growth Rate (2015-2020)
Figure Global Medical Research Institute Sales Growth Rate (2015-2020)
Figure Global Other Sales Growth Rate (2015-2020)
Figure Global Leber Congenital Amaurosis (LCA) Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Leber Congenital Amaurosis (LCA) Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Leber Congenital Amaurosis (LCA) Price and Trend Forecast (2020-2025)
Table Global Leber Congenital Amaurosis (LCA) Sales (K Units) Forecast by Region (2020-2025)
Figure Global Leber Congenital Amaurosis (LCA) Production Market Share Forecast by Region (2020-2025)
Figure North America Leber Congenital Amaurosis (LCA) Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Leber Congenital Amaurosis (LCA) Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Leber Congenital Amaurosis (LCA) Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Leber Congenital Amaurosis (LCA) Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Leber Congenital Amaurosis (LCA) Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Leber Congenital Amaurosis (LCA) Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Leber Congenital Amaurosis (LCA) Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Leber Congenital Amaurosis (LCA) Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table AmpliPhi Biosciences Company Profile
Figure Leber Congenital Amaurosis (LCA) Product Picture and Specifications of AmpliPhi Biosciences
Table Leber Congenital Amaurosis (LCA) Production, Price, Revenue and Gross Margin of 2018-2020
Figure AmpliPhi Biosciences Leber Congenital Amaurosis (LCA) Market Share (2018-2020)
Table AmpliPhi Biosciences Main Business
Table AmpliPhi Biosciences Recent Development
Table ProQR Therapeutics Company Profile
Figure Leber Congenital Amaurosis (LCA) Product Picture and Specifications of ProQR Therapeutics
Table Leber Congenital Amaurosis (LCA) Production, Price, Revenue and Gross Margin of 2018-2020
Figure ProQR Therapeutics Leber Congenital Amaurosis (LCA) Market Share (2018-2020)
Table ProQR Therapeutics Main Business
Table ProQR Therapeutics Recent Development
Table Editas Medicine Company Profile
Figure Leber Congenital Amaurosis (LCA) Product Picture and Specifications of Editas Medicine
Table Leber Congenital Amaurosis (LCA) Production, Price, Revenue and Gross Margin of 2018-2020
Figure Editas Medicine Leber Congenital Amaurosis (LCA) Market Share (2018-2020)
Table Editas Medicine Main Business
Table Editas Medicine Recent Development
Table Novelion Therapeutics Company Profile
Figure Leber Congenital Amaurosis (LCA) Product Picture and Specifications of Novelion Therapeutics
Table Leber Congenital Amaurosis (LCA) Production, Price, Revenue and Gross Margin of 2018-2020
Figure Novelion Therapeutics Leber Congenital Amaurosis (LCA) Market Share (2018-2020)
Table Novelion Therapeutics Main Business
Table Novelion Therapeutics Recent Development
Table Spark Therapeutics Company Profile
Figure Leber Congenital Amaurosis (LCA) Product Picture and Specifications of Spark Therapeutics
Table Leber Congenital Amaurosis (LCA) Production, Price, Revenue and Gross Margin of 2018-2020
Figure Spark Therapeutics Leber Congenital Amaurosis (LCA) Market Share (2018-2020)
Table Spark Therapeutics Main Business
Table Spark Therapeutics Recent Development
Table of Appendix